Lyme disease starts with a single tick bite. The Borrelia spirochete enters the bloodstream and can spread to joints, the brain, the heart, and connective tissue within days. Early symptoms often look like the flu. Some patients develop the classic bull's-eye rash, but many never do, which means the infection goes undiagnosed during the window when treatment is simplest.
Chronic Lyme develops when the initial infection is missed or inadequately treated. The bacteria shifts into survival mode. It changes form, hides inside biofilm colonies, and embeds in tissues where antibiotics have difficulty reaching. The immune system stays activated, cycling between aggressive inflammatory responses and periods of exhaustion. This is why patients experience the relapsing-remitting pattern that makes chronic Lyme so unpredictable.
Standard testing is part of the problem. The two-tier system was designed for population surveillance, not individual diagnosis. It relies on the body producing specific antibodies, which many chronic Lyme patients do not generate in detectable quantities. A negative standard test does not rule out Lyme. Our evaluation uses expanded panels through specialty labs that assess Borrelia through multiple methods, alongside comprehensive co-infection testing for Babesia, Bartonella, Ehrlichia, and Anaplasma. Functional medicine ties the testing into a treatment protocol designed for chronic, multi-system infections.
The Woodlands area carries real exposure risk. Sam Houston National Forest borders the community, and the trail system draws hikers, runners, and families into tick habitat year-round. Gulf Coast humidity keeps tick populations active well into winter. Many of our patients were exposed locally and spent years seeking answers before receiving an accurate diagnosis. Patients dealing with overlapping post-viral conditions like Epstein-Barr reactivation or long COVID often need both addressed in parallel.